 |
| 21-Jan-10 06:01AM | ACCELR8 TECHNOLOGY CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits EDGAR Online -11.39% |
| 19-Jan-10 08:04AM | InPlay: Accelr8 Technology announced the start of a private sale of equity to qualified investors and released updates on corporate events Briefing.com -7.79% |
| 08:00AM | Accelr8 Begins Private Equity Sale and Presents Updates Business Wire |
| 19-Dec-09 01:04PM | ACCELR8 TECHNOLOGY CORP Financials EDGAR Online Financials |
| 15-Dec-09 04:16PM | ACCELR8 TECHNOLOGY CORP Files SEC form 10-Q, Quarterly Report EDGAR Online -11.11% |
| 13-Nov-09 03:32PM | ACCELR8 TECHNOLOGY CORP Files SEC form 10-K, Annual Report EDGAR Online |
| 25-Sep-09 02:29PM | ACCELR8 TECHNOLOGY CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online -32.16% |
| 01:14PM | Accelr8 and Becton Dickinson Conclude Technical Development Project Business Wire |
| 15-Jul-09 08:00AM | Accelr8 Launches Clinical Specimen Study With Combined Test Methods Business Wire |
| 15-Jun-09 08:00PM | Third Quarter 10Q for Accelr8 Technology Corporation WILink |
| 04:03PM | ACCELR8 TECHNOLOGY CORP Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 28-May-09 10:00AM | Accelr8 Presents Data on Rapid Identification of New KPC "Superbug" and Other Multi-Resistant Pathogens Business Wire +48.80% |
| 19-Mar-09 08:55AM | Accelr8 Announces Extension by NYSE and Acceptance of the Company's Plan to Regain Compliance for Continued Listing on the NYSE Alternext US Business Wire |
| 16-Mar-09 03:51PM | ACCELR8 TECHNOLOGY CORP Files SEC form 10-Q, Quarterly Report EDGAR Online +6.47% |
| 12-Feb-09 08:00AM | Accelr8 Announces Collaboration with Denver Health Medical Center in Study of ICU Patients Business Wire |
| 15-Jan-09 06:01AM | ACCELR8 TECHNOLOGY CORP Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta EDGAR Online |
| 06:00AM | Accelr8 Technology Corporation Notified by NYSE Alternext of Continued Listing Standards Non-Compliance Business Wire |
| 15-Dec-08 07:00PM | First Quarter 10Q for Accelr8 Technology Corporation WILink |
| 01:14PM | ACCELR8 TECHNOLOGY CORP Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 06-Nov-08 08:00AM | Accelr8 Announces Study Results with Rapid ESBL Test for Broad Resistance in Gram-Negative Pathogens Business Wire +9.14% |
| 05-Nov-08 07:00PM | Form 10 K for Accelr8 Technology Corporation WILink +13.76% |
| 04-Nov-08 08:00AM | Accelr8 Announces Study Results Projecting the Impact of Rapid Diagnosis on Choice of Initial Therapy in Serious Infections Business Wire +9.96% |
| 29-Oct-08 04:46PM | ACCELR8 TECHNOLOGY CORP Files SEC form 10KSB, Annual Report EDGAR Online |
| 11-Sep-08 08:00AM | Accelr8 Announces Publication of New Study on its OptiChem(R) High-Performance Bio-Coatings Business Wire |
| 04-Sep-08 08:00AM | Accelr8 Announces Independent Study Presentations and New Rapid ESBL Test Business Wire |
| 16-Jun-08 05:08PM | ACCELR8 TECHNOLOGY CORP Files SEC form 10QSB, Quarterly Report EDGAR Online +6.49% |
| 09-Jun-08 08:00AM | Accelr8 Presents Research Results on Direct Bacterial Extraction and 'Superbug' Tests Business Wire |
| 21-May-08 01:15PM | ACCELR8 TECHNOLOGY CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhi EDGAR Online |
| 20-May-08 08:00AM | Accelr8 and BD Sign Research and Licensing Option Agreement for Commercializing Accelr8's BACcel(TM) Rapid Diagnostics Technology Business Wire |
| 01-Apr-08 01:53PM | ACCELR8 TECHNOLOGY CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 18-Mar-08 08:00PM | Second Quarter 10Q for Accelr8 Technology Corporation WILink |
| 17-Mar-08 02:52PM | ACCELR8 TECHNOLOGY CORP Files SEC form 10QSB, Quarterly Report EDGAR Online |
| 03-Jan-08 08:00AM | Accelr8 Announces Research Programs in Two Leading Medical Research Centers Business Wire |
| 02-Jan-08 07:00PM | First Quarter 10Q for Accelr8 Technology Corporation WILink |
| 17-Dec-07 11:15AM | ACCELR8 TECHNOLOGY CORP Files SEC form 10QSB, Quarterly Report EDGAR Online |
| 14-Dec-07 06:02AM | ACCELR8 TECHNOLOGY CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online |
| 13-Dec-07 05:00PM | BD Acquires Right to Negotiate Business Relationship for Accelr8's BACcel(R) Rapid Diagnostics Technology Business Wire |
| 23-Nov-07 09:31AM | Accelr8 Announces Sale of Two New Licenses for OptiChem(R) Surface Coatings Business Wire |
| 29-Oct-07 08:00PM | Form 10 K for Accelr8 Technology Corporation WILink |
| 05:11PM | ACCELR8 TECHNOLOGY CORP Files SEC form 10KSB, Annual Report EDGAR Online |
| 18-Oct-07 05:01PM | Thursday's Small-Cap Winners & Losers at TheStreet.com |
| 08:00AM | Accelr8 Announces Patent Allowance for Rapid Bacterial Diagnostic Method Business Wire |
| 27-Aug-07 08:00AM | Accelr8 Reports New Benchmark for Measuring Bacterial Growth Business Wire |
| 24-Aug-07 03:32PM | ACCELR8 TECHNOLOGY CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 13-Jun-07 04:04PM | ACCELR8 TECHNOLOGY CORP Files SEC form 10QSB, Quarterly Report EDGAR Online |
| 16-Mar-07 05:09PM | ACCELR8 TECHNOLOGY CORP Files SEC form 10QSB, Quarterly Report EDGAR Online |
| 20-Feb-07 02:13PM | ACCELR8 TECHNOLOGY CORP Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
|
|
| Accelr8 Technology Corporation develops materials and instrumentation for applications in medical instrumentation, basic research, drug discovery, and bio-detection in the United States. It manufactures and markets OptiChem surface coatings for use in microarraying components. The company is also developing a program to integrate OptiChem surface chemistry, QuanDx light-scattering quantitative assay instrumentation, and YoDx assay acceleration process into the BACcel system for rapid bacterial identification and antibiotic resistance testing. Accelr8 Technology Corporation was founded in 1982 and is based in Denver, Colorado. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| GERRETSON CHARLES E | Director | Sep 18 | Sale | 3.24 | 1,000 | 3,240 | 140,150 | Sep 22 09:21 AM | | GERRETSON CHARLES E | Director | Sep 17 | Sale | 3.32 | 2,000 | 6,640 | 141,150 | Sep 22 09:21 AM | | GEIMER THOMAS J | CEO and CFO | Aug 26 | Option Exercise | 1.50 | 52,532 | 78,798 | 407,032 | Aug 28 06:57 PM | | Howson David | President | May 07 | Buy | 1.69 | 200 | 338 | 301,200 | May 11 03:29 PM | | Howson David | President | May 05 | Buy | 1.90 | 500 | 950 | 301,000 | May 11 03:29 PM | | Howson David | President | Apr 27 | Buy | 2.00 | 500 | 1,000 | 300,500 | Apr 29 05:54 PM | | Kucera John D. | Director | Mar 03 | Buy | 1.52 | 1,500 | 2,280 | 28,663 | Mar 04 03:49 PM | | Kucera John D. | Director | Mar 02 | Buy | 1.67 | 600 | 1,002 | 27,163 | Mar 04 03:49 PM | | GEIMER THOMAS J | CEO/CFO | Feb 26 | Buy | 1.92 | 300 | 576 | 454,500 | Feb 27 11:31 AM | | GEIMER THOMAS J | CEO/CFO | Feb 24 | Buy | 2.00 | 200 | 400 | 454,200 | Feb 27 11:31 AM | | GERRETSON CHARLES E | Director | Feb 13 | Buy | 2.10 | 1,304 | 2,738 | 143,150 | Feb 19 06:56 PM | | Kucera John D. | Director | Feb 13 | Buy | 1.88 | 2,000 | 3,760 | 26,563 | Feb 19 03:33 PM | | Kucera John D. | Director | Feb 03 | Buy | 2.06 | 1,500 | 3,090 | 24,563 | Feb 05 07:59 PM |
|
|
|
|
|
|
